During the past decade, StemGenex conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "StemGenex" are "Chronic Obstructive Pulmonary Disease" (1 trials), "Multiple Sclerosis" (1 trials), "Osteoarthritis" (1 trials), "Parkinson's Disease" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "StemGenex" in a lesser frequency.

The vast majority of trials in "StemGenex" are 5 trials for "All" genders.

Currently, there are NaN active trials in "StemGenex". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in StemGenex, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in StemGenex, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".